Rapamycin in aging and disease: maximizing efficacy while minimizing side effects
نویسندگان
چکیده
Experimental geroscience has identified rapamycin as a top candidate for promoting healthy aging and longevity in mammals. As multiple independent studies have successfully reproduced the lifespan and healthspan promoting effects of rapamycin, the focus has shifted to possible translational use. While a promising compound, clinical use of rapamycin is limited by concerns of side effects associated with the drug. Studies aimed at defining optimal dosage regimen, delivery route, and formulation will allow for benefits to be maximized while reducing side effects.
منابع مشابه
From rapalogs to anti-aging formula
Inhibitors of mTOR, including clinically available rapalogs such as rapamycin (Sirolimus) and Everolimus, are gerosuppressants, which suppress cellular senescence. Rapamycin slows aging and extends life span in a variety of species from worm to mammals. Rapalogs can prevent age-related diseases, including cancer, atherosclerosis, obesity, neurodegeneration and retinopathy and potentially rejuve...
متن کاملAlternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system
Inhibition of the mechanistic target of rapamycin (mTOR) signaling pathway by the FDA-approved drug rapamycin has been shown to promote lifespan and delay age-related diseases in model organisms including mice. Unfortunately, rapamycin has potentially serious side effects in humans, including glucose intolerance and immunosuppression, which may preclude the long-term prophylactic use of rapamyc...
متن کاملmTORC2 takes the longevity stAGE
Rapamycin, a FDA-approved pharmaceutical, has received significant attention as a possible anti-aging agent since the groundbreaking discovery in 2009 that rapamycin treatment significantly extends the lifespan of mice [1]. Excitingly, rapamycin not only extends lifespan, it also extends healthspan in rodent models, preventing and delaying the onset of age-related diseases, including cancer and...
متن کاملAging interventions get human
Over the last three decades, aging research has made great strides. At least in non-vertebrate animal models such as yeast and worms, it is possible to extend lifespan through reduced or ablated expression of hundreds of genes. The number of genes tested in mice are substantially less but the data so far is consistent with modulation of aging by numerous genes and pathways. More importantly, ev...
متن کاملFuzzy Multi-objective Permutation Flow Shop Scheduling Problem with Fuzzy Processing Times under Learning and Aging Effects
In industries machine maintenance is used in order to avoid untimely machine fails as well as to improve production effectiveness. This research regards a permutation flow shop scheduling problem with aging and learning effects considering maintenance process. In this study, it is assumed that each machine may be subject to at most one maintenance activity during the planning horizon. The objec...
متن کامل